Review

chromosomal microarray (Genetic Analysis AS)

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

Genetic Analysis AS chromosomal microarray
Summary of <t>chromosomal</t> <t>microarray</t> results. CNV—copy number variations, bCNV—benign copy number variations, pCNV—pathogenic copy number variations, LB—likely-benign, LP—likely-pathogenic, VOUS—Variant of unknown significance.

Summary of <t>chromosomal</t> <t>microarray</t> results. CNV—copy number variations, bCNV—benign copy number variations, pCNV—pathogenic copy number variations, LB—likely-benign, LP—likely-pathogenic, VOUS—Variant of unknown significance.

Chromosomal Microarray, supplied by Genetic Analysis AS, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/chromosomal+microarray+analysis/chromosomal+microarray/pmc07551065-64-0-9
Average 90 stars, based on 1 article reviews

chromosomal microarray - by Bioz Stars, 2026-11

90/100 stars

Images

1) Product Images from "Relationship between Clinical Parameters and Chromosomal Microarray Data in Infants with Developmental Delay"

Article Title: Relationship between Clinical Parameters and Chromosomal Microarray Data in Infants with Developmental Delay

Journal: Healthcare

doi: 10.3390/healthcare8030305

Summary of chromosomal microarray results. CNV—copy number variations, bCNV—benign copy number variations, pCNV—pathogenic copy number variations, LB—likely-benign, LP—likely-pathogenic, VOUS—Variant of unknown significance.

Figure Legend Snippet: Summary of chromosomal microarray results. CNV—copy number variations, bCNV—benign copy number variations, pCNV—pathogenic copy number variations, LB—likely-benign, LP—likely-pathogenic, VOUS—Variant of unknown significance.

Techniques Used: Microarray, Variant Assay

Clinical features and parameters with chromosomal microarray (CMA) in 35 infants with developmental delay and abnormalities in copy number variations.

Figure Legend Snippet: Clinical features and parameters with chromosomal microarray (CMA) in 35 infants with developmental delay and abnormalities in copy number variations.

Techniques Used: Microarray

Prevalence of cardiac anomaly, autism spectrum disorder, facial dysmorphism, and brain anomaly in pathogenic and VOUS-likely pathogenic CNV groups versus VOUS with no sub-classification, VOUS-likely benign, benign, and normal CNVs groups. CMA—chromosomal microarray analysis, BW—body weight, ASD—autism spectrum disorder, pCNV—pathogenic copy number variations, LP—likely-pathogenic, VOUS—Variant of unknown significance. * p < 0.05.

Figure Legend Snippet: Prevalence of cardiac anomaly, autism spectrum disorder, facial dysmorphism, and brain anomaly in pathogenic and VOUS-likely pathogenic CNV groups versus VOUS with no sub-classification, VOUS-likely benign, benign, and normal CNVs groups. CMA—chromosomal microarray analysis, BW—body weight, ASD—autism spectrum disorder, pCNV—pathogenic copy number variations, LP—likely-pathogenic, VOUS—Variant of unknown significance. * p < 0.05.

Techniques Used: Microarray, Variant Assay

Prevalence of cardiac anomaly, autism spectrum disorder, facial dysmorphism, and brain anomaly in pathogenic, VOUS-likely pathogenic CNV groups, and VOUS with no sub-classification versus VOUS-likely benign, benign, and normal CNVs groups. CMA—chromosomal microarray analysis, BW—body weight, ASD—autism spectrum disorder, pCNV—pathogenic copy number variations, LP—likely-pathogenic, VOUS—Variant of unknown significance, VOUS no classification—VOUS with no-subclassification.

Figure Legend Snippet: Prevalence of cardiac anomaly, autism spectrum disorder, facial dysmorphism, and brain anomaly in pathogenic, VOUS-likely pathogenic CNV groups, and VOUS with no sub-classification versus VOUS-likely benign, benign, and normal CNVs groups. CMA—chromosomal microarray analysis, BW—body weight, ASD—autism spectrum disorder, pCNV—pathogenic copy number variations, LP—likely-pathogenic, VOUS—Variant of unknown significance, VOUS no classification—VOUS with no-subclassification.

Techniques Used: Microarray, Variant Assay

Microarray:

Article Title: Relationship between Clinical Parameters and Chromosomal Microarray Data in Infants with Developmental Delay
Article Snippet: .. Chromosomal microarray (CMA) is considered a first-tier test for genetic analysis as it can be used to examine gene copy number variations (CNVs) throughout the entire genome, with enhanced sensitivity for detecting submicroscopic deletions and duplications. ..

Review

chromosomal microarray (Genetic Analysis AS)

Structured Review

Images

1) Product Images from "Relationship between Clinical Parameters and Chromosomal Microarray Data in Infants with Developmental Delay"

Related Articles

Microarray:

Similar Products

Image Search Results